No Data
No Data
TD Cowen Maintains Lantheus(LNTH.US) With Buy Rating, Maintains Target Price $110
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 A.m. Eastern Time
Lantheus Stock Buy Rating Supported by Increased Pylarify Revenue Projections and Updated EPS Estimates
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Press Release: Lantheus Completes Acquisition of Evergreen Theragnostics
thoughtful Bat_8163 : i have noticed this company 6 years ago as it merges with Progenics, one of my holdings. Amazing development!